- Home
- ORKA vs MAN Comparison
ORKA vs MAN Comparison
Compare ORKA & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORKA | MAN |
|---|---|---|
| Founded | 2004 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | ORKA | MAN |
|---|---|---|
| Price | $32.93 | $29.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | ★ $52.70 | $39.67 |
| AVG Volume (30 Days) | 291.8K | ★ 1.5M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,957,100,000.00 |
| Revenue This Year | N/A | $5.26 |
| Revenue Next Year | N/A | $3.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.58 |
| 52 Week Low | $5.49 | $25.15 |
| 52 Week High | $36.53 | $63.35 |
Technical Indicators
Market Signals| Indicator | ORKA | MAN |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 49.35 |
| Support Level | $25.65 | $28.26 |
| Resistance Level | $36.52 | $29.26 |
| Average True Range (ATR) | 1.94 | 1.57 |
| MACD | -0.11 | 0.09 |
| Stochastic Oscillator | 33.88 | 78.09 |
Price Performance
Historical ComparisonAbout ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.